Qiagen Launches Generic Sample Preparation Kit

The first CE-marked generic sample preparation kit fulfilling the requirements of the European Union's recent in vitro diagnostic directive has been launched by Qiagen N.V. (Venlo, The Netherlands).

This new QIAamp DSP DNA Blood Mini Kit is developed, produced, and quality controlled according to all requirements of the CE in vitro diagnostic directive. High-risk products such as HIV testing systems, blood glucose testing systems, and nucleic acid purification products used in diagnostic workflow are affected by this new regulatory framework. The major goals of the directive are to standardize diagnostic procedures, increase reliability of diagnostic analysis, and enhance patient safety through the highest level of product safety.

"Qiagen is once again setting standards by launching the first CE-marked nucleic acid purification product,” said Noel Doheny, vice president, Solutions for Molecular Diagnostics, Qiagen. "The development and launch of this product allows diagnostic customers to select a product which offers them full compliance with the in vitro diagnostic directive, safety in regard to nucleic acid purification from blood, and highest efficiency through easy integration into diagnostic workflows.”


Related Links:
Qiagen